BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4006375)

  • 1. Clinical pharmacology of 5-iodo-2'-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation.
    Klecker RW; Jenkins JF; Kinsella TJ; Fine RL; Strong JM; Collins JM
    Clin Pharmacol Ther; 1985 Jul; 38(1):45-51. PubMed ID: 4006375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme.
    Kinsella TJ; Collins J; Rowland J; Klecker R; Wright D; Katz D; Steinberg SM; Glastein E
    J Clin Oncol; 1988 May; 6(5):871-9. PubMed ID: 2835444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
    Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
    Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 5-iodouracil on the growth and biosynthetic processes of bacteriophage T4td8 in the absence of light.
    Byrd DM; Prusoff WH
    Chem Biol Interact; 1976 Feb; 12(2):197-210. PubMed ID: 764990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical modulation of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
    Stetson PL; Normolle DP; Knol JA; Johnson NJ; Yang ZM; Sakmar E; Prieskorn D; Terrio P; Knutsen CA; Ensminger WD
    J Natl Cancer Inst; 1991 Nov; 83(22):1659-67. PubMed ID: 1836238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer.
    Schilsky RL; Janisch L; Berezin F; Mick R; Vogelzang NJ; Ratain MJ
    Cancer Res; 1993 Mar; 53(6):1293-6. PubMed ID: 7680282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutual kinetic interaction between 5-fluorouracil and bromodeoxyuridine or iododeoxyuridine in dogs.
    Smith DE; Brenner DE; Knutsen CA; Deremer SJ; Terrio PA; Johnson NJ; Stetson PL; Ensminger WD
    Drug Metab Dispos; 1993; 21(2):277-83. PubMed ID: 8097697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd).
    Galanis E; Goldberg R; Reid J; Atherton P; Sloan J; Pitot H; Rubin J; Adjei AA; Burch P; Safgren SL; Witzig TE; Ames MM; Erlichman C
    Ann Oncol; 2001 May; 12(5):701-7. PubMed ID: 11432631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of iododeoxyuridine and its primary metabolite, iodouracil on radiation response.
    Kinsella TJ; Dobson PP; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1519-22. PubMed ID: 3759574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2'-deoxyribonucleosides.
    Fukushima M; Suzuki N; Emura T; Yano S; Kazuno H; Tada Y; Yamada Y; Asao T
    Biochem Pharmacol; 2000 May; 59(10):1227-36. PubMed ID: 10736423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
    Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
    Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of hepatic artery infusion of 5-iodo-2'-deoxyuridine and 5-fluorouracil in patients with advanced hepatic malignancy: biochemically based combination chemotherapy.
    Remick SC; Benson AB; Weese JL; Willson JK; Ramirez G; Wirtanen GW; Alberti DB; Nieting LM; Tutsch KD; Fischer PH
    Cancer Res; 1989 Nov; 49(22):6437-42. PubMed ID: 2804987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of thymidine phosphorylase from Escherichia coli and its photoinactivation in the presence of thymine, thymidine, and some halogenated analogs.
    Voytek P
    J Biol Chem; 1975 May; 250(10):3660-5. PubMed ID: 236298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE EFFECT OF NATURAL AND UNNNATURAL PYRIMIDINES AND PYRIMIDINE NUCLEOSIDES ON THE PHOSPHOROLYSIS OF 5-IODODEOXYURIDINE BY MOUSE LIVER EXTRACT.
    KRISS JP; BOND SB
    Biochem Pharmacol; 1964 Mar; 13():365-70. PubMed ID: 14157596
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study.
    Speth PA; Kinsella TJ; Belanger K; Klecker RW; Smith R; Rowland JB; Collins JM
    Cancer Res; 1988 May; 48(10):2933-7. PubMed ID: 2965970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lethal and mutagenic effects of 5-iodouracil on bacteriophage T4td8rII.
    Byrd DM; Prusoff WH
    Antimicrob Agents Chemother; 1977 Feb; 11(2):312-7. PubMed ID: 848938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
    Fischer PH; Weddle MA; Mossie RD
    Mol Pharmacol; 1983 May; 23(3):709-16. PubMed ID: 6865913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state arterial and hepatic venous plasma concentrations of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine in animals--drugs which are subject to both splanchnic and extra-splanchnic elimination.
    Wagner JG; Stetson PL; Knol JA; Andrews JC; Walker-Andrews S; Knutsen CA; Johnson N; Prieskorn D; Terrio P; Yang Z
    Sel Cancer Ther; 1989; 5(4):193-203. PubMed ID: 2623384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.
    McGinn CJ; Kunugi KA; Tutsch KD; Feierabend C; Alberti D; Lindstrom MJ; Wilding G; Arzoomanian RZ; Kinsella TJ
    Clin Cancer Res; 1996 Aug; 2(8):1299-305. PubMed ID: 9816300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
    Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
    Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.